Circio Holding ASA (OSL:CRNA)

Norway flag Norway · Delayed Price · Currency is NOK
0.7110
-0.0190 (-2.60%)
At close: May 9, 2025
-68.12%
Market Cap 63.39M
Revenue (ttm) n/a
Net Income (ttm) 57.52M
Shares Out 90.81M
EPS (ttm) 2.79
PE Ratio 0.25
Forward PE 1.09
Dividend n/a
Ex-Dividend Date n/a
Volume 746,811
Average Volume 1,745,878
Open 0.6800
Previous Close 0.7300
Day's Range 0.6800 - 0.7290
52-Week Range 0.5400 - 13.2000
Beta 1.52
RSI 53.10
Earnings Date Aug 28, 2025

About Circio Holding ASA

Circio Holding ASA, a biotechnology company, develops novel circular RNA and immunotherapy medicines. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a collaboration with Certest Biotec, S.L. for formulation of circVec. The company was formerly known as Targovax ASA and changed its name to Circio Holdi... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 10
Stock Exchange Oslo Børs
Ticker Symbol CRNA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.